Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

749 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ; Graft-vs-Host Disease Working Committee of the CIBMTR. Arai S, et al. Among authors: blaise d. Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74. doi: 10.1016/j.bbmt.2014.10.021. Epub 2014 Oct 30. Biol Blood Marrow Transplant. 2015. PMID: 25445023 Free PMC article.
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.
Nguyen S, Leblanc T, Fenaux P, Witz F, Blaise D, Pigneux A, Thomas X, Rigal-Huguet F, Lioure B, Auvrignon A, Fière D, Reiffers J, Castaigne S, Leverger G, Harousseau JL, Socié G, Dombret H. Nguyen S, et al. Among authors: blaise d. Blood. 2002 May 15;99(10):3517-23. doi: 10.1182/blood.v99.10.3517. Blood. 2002. PMID: 11986202 Free article.
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.
Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X, Delannoy A, Buzyn A, Bilhou-Nabera C, Cayuela JM, Fenaux P, Bourhis JH, Fegueux N, Charrin C, Boucheix C, Lhéritier V, Espérou H, MacIntyre E, Vernant JP, Fière D; Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group). Dombret H, et al. Among authors: blaise d. Blood. 2002 Oct 1;100(7):2357-66. doi: 10.1182/blood-2002-03-0704. Blood. 2002. PMID: 12239143 Free article.
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study.
Mohty M, Kuentz M, Michallet M, Bourhis JH, Milpied N, Sutton L, Jouet JP, Attal M, Bordigoni P, Cahn JY, Boiron JM, Blaise D; Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Mohty M, et al. Among authors: blaise d. Blood. 2002 Nov 1;100(9):3128-34. doi: 10.1182/blood.V100.9.3128. Blood. 2002. PMID: 12384409 Free article. Clinical Trial.
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Delaunay J, Vey N, Leblanc T, Fenaux P, Rigal-Huguet F, Witz F, Lamy T, Auvrignon A, Blaise D, Pigneux A, Mugneret F, Bastard C, Dastugue N, Van den Akker J, Fière D, Reiffers J, Castaigne S, Leverger G, Harousseau JL, Dombret H; French Acute Myeloid Leukemia Intergroup; Groupe Ouest-Est des Leucémies Aiguës Myéoblastiques; Leucémies Aiguës Myéoblastiques de l'Enfant; Acute Leukemia French Association; Bordeaux-Grenoble-Marseille-Toulouse cooperative groups. Delaunay J, et al. Among authors: blaise d. Blood. 2003 Jul 15;102(2):462-9. doi: 10.1182/blood-2002-11-3527. Epub 2003 Mar 20. Blood. 2003. PMID: 12649129 Free article. Review.
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O, Vey N, Stoppa AM, Coso D, Chabannon C, Viens P, Maraninchi D, Blaise D. Mohty M, et al. Among authors: blaise d. Blood. 2003 Jul 15;102(2):470-6. doi: 10.1182/blood-2002-12-3629. Epub 2003 Mar 20. Blood. 2003. PMID: 12649133 Free article.
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.
Blaise D, Bay JO, Faucher C, Michallet M, Boiron JM, Choufi B, Cahn JY, Gratecos N, Sotto JJ, François S, Fleury J, Mohty M, Chabannon C, Bilger K, Gravis G, Viret F, Braud AC, Bardou VJ, Maraninchi D, Viens P. Blaise D, et al. Blood. 2004 Jan 15;103(2):435-41. doi: 10.1182/blood-2003-07-2236. Epub 2003 Aug 28. Blood. 2004. PMID: 12946991 Free article.
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.
Faucher C, Mohty M, Vey N, Gaugler B, Bilger K, Moziconnacci MJ, Stoppa AM, Coso D, Ladaique P, Chabannon C, Reviron D, Maraninchi D, Gastaut JA, Olive D, Blaise D. Faucher C, et al. Among authors: blaise d. Exp Hematol. 2003 Oct;31(10):873-80. doi: 10.1016/s0301-472x(03)00194-2. Exp Hematol. 2003. PMID: 14550802 Free article.
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).
Garderet L, Labopin M, Gorin NC, Polge E, Baruchel A, Meloni G, Ortega J, Vossen J, Bunjes D, Leverger G, Blaise D, Ferrant A, Brune M, Dore E, Gadner H, Zintl F, Yaniv I, Dini G, Frassoni F; Acute Leukemia Working Party and Pediatric Working Party of the European Group for Blood and Marrow Transplantation. Garderet L, et al. Among authors: blaise d. Blood. 2005 Jan 1;105(1):405-9. doi: 10.1182/blood-2004-03-1103. Epub 2004 Jun 10. Blood. 2005. PMID: 15191953 Free article.
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Mohty M, Bagattini S, Chabannon C, Faucher C, Bardou VJ, Bilger K, Vey N, Gaugler B, Stoppa AM, Coso D, Ladaique P, Olive D, Viens P, Blaise D. Mohty M, et al. Among authors: blaise d. Exp Hematol. 2004 Nov;32(11):1097-102. doi: 10.1016/j.exphem.2004.07.020. Exp Hematol. 2004. PMID: 15539088 Free article. Clinical Trial.
749 results